• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Introduction to Tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate (CAS No. 2306271-52-1)

Tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate (CAS No. 2306271-52-1) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the spirocyclic class of molecules, characterized by its unique structural framework which consists of two fused rings connected by a nitrogen atom. The presence of both cyano and carboxylate functional groups makes it a versatile intermediate in the synthesis of various bioactive molecules.

The molecular structure of tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate imparts several advantageous properties that make it valuable in drug discovery and development. The spirocyclic core enhances the rigidity and stability of the molecule, while the cyano group can serve as a handle for further functionalization through reactions such as hydrolysis or reduction. Additionally, the carboxylate moiety provides a site for salt formation, which is crucial for improving solubility and pharmacokinetic properties.

In recent years, there has been growing interest in spirocyclic compounds due to their potential applications in the treatment of various diseases. Spirocycles are known for their ability to mimic natural products and have been found to exhibit a wide range of biological activities. For instance, spirocyclic scaffolds have shown promise in the development of antiviral, anticancer, and anti-inflammatory agents. The specific arrangement of atoms in tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate makes it an attractive candidate for further exploration in these areas.

One of the most compelling aspects of this compound is its potential as a building block for more complex molecules. The tert-butyl group provides steric hindrance, which can be beneficial in designing molecules with improved binding affinity and selectivity. This feature is particularly important in drug design, where precise interactions between a drug molecule and its target are critical for efficacy. Researchers have leveraged similar structural motifs to develop novel therapeutic agents that exhibit high potency and low toxicity.

The cyano group in tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate also plays a significant role in its reactivity and functionality. This group can be easily transformed into other functional moieties, such as amides or esters, through standard chemical transformations. These modifications can be tailored to fine-tune the pharmacological properties of the resulting compounds. For example, introducing an amide linkage can enhance cell permeability, while an ester group might improve metabolic stability.

Recent studies have highlighted the importance of spirocyclic compounds in modulating biological pathways associated with neurological disorders. The rigid structure of these molecules allows them to interact with biological targets in a precise manner, often leading to higher selectivity compared to linear analogs. In particular, derivatives of spirocyclic azaspiropyrans have shown potential in treating conditions such as Alzheimer's disease and Parkinson's disease by inhibiting key enzymes involved in neurodegeneration.

The synthesis of tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate involves multi-step organic transformations that require careful optimization to achieve high yields and purity. Common synthetic routes include cyclization reactions followed by functional group interconversions. Advances in synthetic methodologies have enabled chemists to construct complex spirocyclic frameworks with greater ease and efficiency, paving the way for rapid discovery and development of novel bioactive compounds.

The pharmaceutical industry has been particularly interested in leveraging spirocyclic compounds due to their unique structural features and biological activities. Companies are actively exploring these molecules as leads for new drugs targeting various therapeutic areas. The versatility of tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate as a synthetic intermediate makes it a valuable asset in medicinal chemistry libraries, providing researchers with a rich palette of structural motifs to explore.

In conclusion, tert-butyl 9-cyano-2-azaspiro[5.5]undecane-2-carboxylate (CAS No. 2306271-52-1) represents a promising compound with significant potential in pharmaceutical research and drug development. Its unique structural features, combined with its reactivity and functionality, make it an attractive candidate for further exploration in various therapeutic areas. As research continues to uncover new applications for spirocyclic compounds, this molecule is likely to play an increasingly important role in the discovery and development of next-generation therapeutics.

• 2121081-15-8(5-Azaspiro[2.5]octane-5-carboxylic acid, 8-cyano-, 1,1-dimethylethyl ester)
• 915226-39-0(tert-butyl (3S)-3-cyanopiperidine-1-carboxylate)
• 91419-53-3(tert-butyl 3-cyanopiperidine-1-carboxylate)
• 2097976-05-9(Tert-butyl 4-cyano-3-ethylpiperidine-1-carboxylate)
• 1823484-78-1(Tert-butyl 6-cyano-3-azabicyclo[3.1.1]heptane-3-carboxylate)
• 1341036-62-1(3-Boc-8-cyano-3-azabicyclo[3.2.1]octane)
• 915226-44-7(tert-butyl (3R)-3-cyanopiperidine-1-carboxylate)
• 1207178-51-5(Tert-butyl 4-(aminomethyl)-4-cyanopiperidine-1-carboxylate)
• 1374658-96-4(Tert-butyl 2-cyano-6-azaspiro[3.5]nonane-6-carboxylate)
• 2119343-02-9(tert-butyl 9-cyano-3-azabicyclo[3.3.1]nonane-3-carboxylate)